Peptide Stacking Guide

Peptide stacking is the practice of using two or more peptides simultaneously to achieve a combined effect greater than either peptide alone. The core idea is complementary pathways — each peptide in the stack targets a different mechanism, and the combined result is additive or synergistic.

This is not unique to peptides. The concept mirrors combination therapy in medicine, where drugs with different mechanisms are paired to improve outcomes (e.g., cancer chemotherapy, HIV antiretrovirals, blood pressure management). The difference is that most peptide stacks are based on mechanistic reasoning and community experience rather than controlled clinical trials testing the specific combination.

The goal of stacking is to cover more biological ground than a single peptide can. A healing stack might pair one peptide that promotes blood vessel formation with another that drives cell migration to the injury site. A GH stack might combine a peptide that tells the pituitary to release growth hormone with another that amplifies that signal. Each peptide handles a different piece of the puzzle.

This is the most widely used peptide stack in the community, primarily for injury recovery, tendon and ligament repair, and general tissue healing.

BPC-157 (Body Protection Compound) is a gastric pentadecapeptide that drives angiogenesis — the formation of new blood vessels. It upregulates VEGF (vascular endothelial growth factor) and promotes nitric oxide production, increasing blood flow to damaged tissue. It also modulates the FAK-paxillin pathway involved in cell survival and migration at injury sites.

TB-500 (Thymosin Beta-4) works through a different mechanism. Its primary action is upregulating actin, a cell-building protein that plays a critical role in cell migration, proliferation, and differentiation. TB-500 enables cells to physically move to the site of injury and begin repair. It also has anti-inflammatory and anti-fibrotic properties, helping to reduce scar tissue formation.

Why they stack well: BPC-157 builds the vascular infrastructure (new blood vessels to deliver nutrients and oxygen), while TB-500 mobilizes the repair cells that use that infrastructure. Different inputs, same output — faster, more complete healing.

This is the gold standard growth hormone secretagogue stack, combining two peptides that stimulate GH release through completely different receptor pathways.

CJC-1295 (with or without DAC) is a growth hormone-releasing hormone (GHRH) analog. It binds to the GHRH receptor on the pituitary gland and tells it to produce and release growth hormone. Think of it as pressing the accelerator.

Ipamorelin is a ghrelin mimetic — a growth hormone-releasing peptide (GHRP) that binds to the ghrelin/GHS receptor. It amplifies the pituitary's GH output by a separate mechanism. Think of it as removing the brakes while also pressing a second accelerator.

When used alone, each peptide produces a moderate GH pulse. When combined, the effect is multiplicative — studies on GHRH + GHRP combinations show 3–5x greater GH release compared to either peptide alone. This synergy is well-documented in endocrinology literature and is the primary reason this stack exists.

This pairing comes directly from Russian clinical practice, where both peptides are approved prescription medications. Semax and Selank are frequently prescribed together for cognitive enhancement, stress resilience, and neurological recovery.

Semax is a synthetic analog of ACTH(4-10) — a fragment of adrenocorticotropic hormone. Its primary cognitive mechanism is robust upregulation of BDNF (brain-derived neurotrophic factor), the key protein for neuronal growth, synaptic plasticity, and memory formation. Semax also increases dopamine and serotonin turnover in the prefrontal cortex, producing noticeable improvements in focus, motivation, and mental clarity.

Selank is a synthetic analog of tuftsin, an immunomodulatory peptide. Its cognitive effects come from anxiolytic (anti-anxiety) action mediated through modulation of GABA and monoamine systems. Selank reduces anxiety without sedation — unlike benzodiazepines, it does not impair cognition, cause drowsiness, or carry dependence risk. It also has its own mild BDNF-enhancing effects.

The stack logic: Semax provides the drive — increased BDNF, sharper focus, more motivation. Selank provides the calm — reduced anxiety and mental noise without blunting the cognitive boost. The result is focused clarity without jitteriness or overstimulation.

This stack originates from the work of Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Khavinson's bioregulation framework is based on the idea that short peptides (2–4 amino acids) serve as endogenous gene regulators, and that supplementing these peptides can restore function to aging organs.

Epitalon (Epithalon, AEDG peptide) is a synthetic tetrapeptide that targets the pineal gland. Its proposed mechanism is reactivation of telomerase — the enzyme that maintains telomere length. Telomere shortening is a hallmark of cellular aging. Epitalon also normalizes melatonin production from the pineal gland, which declines significantly with age, affecting circadian rhythm, sleep quality, and antioxidant defense.

Thymalin (EW peptide) targets the thymus — the immune organ that atrophies dramatically after puberty. Thymic involution is a major driver of immune aging (immunosenescence). Thymalin is proposed to restore thymic function, improving T-cell maturation and overall immune competence.

The stack logic: Epitalon addresses cellular aging at the telomere level and restores circadian/pineal function. Thymalin addresses immune aging by supporting the thymus. Together, they target two of the most significant pillars of biological aging — cellular senescence and immune decline.

This is a body composition stack targeting fat loss through two completely independent metabolic pathways.

Semaglutide is a GLP-1 receptor agonist. It mimics the incretin hormone GLP-1, which is released by the gut after eating. Its effects include significant appetite suppression (via hypothalamic signaling), delayed gastric emptying (food stays in the stomach longer, increasing satiety), and improved insulin sensitivity. Semaglutide is FDA-approved for both diabetes (Ozempic) and weight management (Wegovy) and has the strongest clinical evidence base of any peptide for fat loss.

5-Amino-1MQ is a small molecule (technically not a peptide, but frequently discussed alongside them) that inhibits NNMT (nicotinamide N-methyltransferase), an enzyme highly expressed in fat tissue. NNMT inhibition shifts fat cells from energy storage toward energy expenditure, increases NAD+ levels in adipocytes, and activates SIRT1 — a key longevity and metabolic gene. In preclinical studies, NNMT inhibition reduced fat mass without affecting food intake.

The stack logic: Semaglutide reduces caloric intake from the top down (appetite and satiety signaling). 5-Amino-1MQ attacks fat metabolism from the bottom up (cellular energy balance in adipocytes). One makes you eat less, the other makes your fat cells burn more. These are entirely non-overlapping mechanisms.

Peptide stacking introduces additional complexity and risk compared to using a single peptide. Most of these combinations have never been tested together in controlled clinical trials. The stacks described above are based on mechanistic reasoning and community experience — not on clinical evidence proving the specific combination is safe or effective.

Key principles for safer stacking:

— Start peptides one at a time. Introduce each peptide individually for at least 5–7 days before adding the next one. This allows you to isolate which peptide is responsible for any effects (positive or negative). If you start two peptides on the same day and develop a side effect, you will not know which one caused it.

— Do not combine peptides with overlapping mechanisms unless you understand the dose-response implications. Stacking two GH secretagogues on top of each other (e.g., Ipamorelin + GHRP-6 + MK-677) can push GH and IGF-1 to supraphysiological levels, increasing risk of insulin resistance, joint pain, and long-term health effects.

— Monitor bloodwork. If you are running GH stacks, check IGF-1 and fasting glucose. If you are running metabolic stacks, monitor metabolic panels. Blood work is how you catch problems before they become symptoms.

— More is not better. Resist the temptation to add additional peptides to an already working stack. Each addition increases unknown interaction risk with diminishing marginal benefit.

— Interactions with prescription medications are largely unstudied. If you take any prescription drugs, discuss peptide use with your healthcare provider.

— Keep detailed logs of dosing, timing, and subjective effects. If something goes wrong, a log helps your doctor (and you) identify the cause.